The Rabid Capitalist

Professor Glenn A. Okun

The Rabid Capitalist: The Big Point is a brief summary of a detailed note available to paid subscribers.

Private credit, as predicted by the Rabid Capitalist, has established itself as the superior asset class to private equity (see https://therabidcapitalist.com/2023/08/03/another-looming-debt-crisis-and-an-investment-opportunity/, https://therabidcapitalist.com/2023/08/04/bdcs-are-positioned-to-profit-from-the-coming-credit-crunch/, https://therabidcapitalist.com/2023/08/06/the-business-development-company-bdc-investment-strategy-2/ and https://therabidcapitalist.com/2023/09/11/the-wsj-reports-on-bdc-investments-5-weeks-after-the-rabid-capitalist/).  According to the State Street Private Equity Index, which tracks approximately 3,900 funds with $4.8 trillion in capital commitments, private credit has beaten private equity funds not only in the second quarter of 2023 but also in five of the last six quarters since the beginning of 2022. 

The Rabid Capitalist’s business development portfolio has generated outstanding performance.  It has provided total returns of 5% since its recommendation on August 4.  This has exceeded the private equity fund return by approximately 150% over the time period.  It has surpassed the 1.39% gain in the Russell 3000 index by 361 basis points.  Yes, these fixed income investment vehicles have beaten stock market returns by a wide margin.

The Rabid Capitalist’s business development company portfolio and additional investment ideas and analysis are available to paid subscribers.

Complete content is available for a $15 monthly subscription.  Click here to subscribe: